Pifeltro (doravirine) is a small molecule pharmaceutical. Doravirine was first approved as Pifeltro on 2018-08-30. It is used to treat hiv-1 in the USA. It has been approved in Europe to treat HIV infections. Delstrigo's patent is valid until 2031-10-07 (FDA).
|Indication||hiv infections, hiv-1|
|Drug Class||Antivirals: non-nucleoside reverse transcriptase inhibitors, not benzoxazinone derivatives|